Medicine

3 Minutes
Medicine

Bespak and Orbia unite to accelerate transition to climate-friendly inhalers

Key Highlights: Bespak and Orbia Advance Corporation announced a collaboration intended to accelerate the transition to climate-friendly inhalers utilising Orbia Fluor & Energy Materials’ low global warming potential propellant known as Zephex 152a. The shared aim of the...
Read More
3 Minutes
Medicine

Yourgene Health Cystic Fibrosis Base assay receives IVDR accreditation

Key Highlights: Yourgene Health announced that it has received accreditation under the new EU requirements of the in vitro diagnostic regulation (IVDR) for the Yourgene Cystic Fibrosis Base assay.  The Yourgene Cystic Fibrosis Base assay uses amplification-refractory mutation system technology and genetic analysers...
Read More
2 Minutes
Medicine

Synexa expands bioanalysis capabilities with Alderley acquisition

Key Highlights: Synexa Life Sciences announced the acquisition of Alderley Analytical Ltd, reflecting an important milestone in Synexa’s ‘buy and build’ growth strategy. Alderley Analytical’s services complement Synexa Life Sciences’ established capabilities in biomarker and bioanalytical assays—covering...
Read More
2 Minutes
Medicine

Recipharm and Exela announce exclusive strategic alliance for sterile manufacturing

Key Highlights: Recipharm and Exela Pharma Sciences announced an exclusive strategic alliance aimed at enhancing sterile manufacturing capabilities in the United States. This collaboration will provide Recipharm with access to Exela’s manufacturing facility located in Lenoir,...
Read More
5 Minutes
Medicine

Lessening the regulatory burden for medical device suppliers: pharma best practice around structured data re-use

Lessons learned in pharma around product data and associated content management offer some useful shortcuts for the medical device sector as its own regulatory workload multiplies. Celegence’s Sonia Veluchamy offers advice in the light...
Read More
2 Minutes
Medicine

Barinthus Bio intiates Phase 1 clinical trial of VTP-1000 for treatment of coeliac disease

Barinthus Biotherapeutics plc, a clinical-stage biopharmaceutical company developing novel immunotherapeutic candidates that guide T cells to control disease, has announced the initiation of its first-in-human Phase 1 trial of VTP-1000 in adults with coeliac...
Read More
2 Minutes
Medicine

Bormioli Pharma and Asamedic announce partnership for ‘life-saving’ drug Coxor

Asamedic, a pioneer in emergency medical treatment of myocardial infarction, and Bormioli Pharma, a leader in pharmaceutical packaging solutions, have announced a partnership for the commercialisation of Coxor 300mg Acetylsalicylic acid, a ‘revolutionary life-saving medication’ designed...
Read More
1 Minute
Medicine

Arrowhead Pharmaceuticals’ Plozasiran Receives Breakthrough Therapy Designation from the FDA

Arrowhead Pharmaceuticals has been granted breakthrough therapy designation from the US Food and Drug Administration (FDA) regarding its potential RNA interference (RNAi) therapeutic, plozasiran. The treatment is said to have shown “promising results” in trials...
Read More
2 Minutes
Medicine

Antabio completes Phase 1 clinical study of MEM-ANT3310 for severe hospital infections

Antabio, a private biopharmaceutical company developing novel and highly differentiated antibacterial treatments for critical priority pathogens, with a particular focus on life-threatening respiratory infections, has announced that it has completed the Phase 1 clinical...
Read More
1 Minute
Medicine

Pfizer Launches Direct-to-Consumer Service – European Pharmaceutical Manufacturer

Pfizer has unveiled its direct-to-consumer service which will help users schedule telehealth appointments, fill prescriptions, and access saving programs for the company’s COVID-19, migraine, and influenzas treatments. Dubbed PfizerForAll, people will also be able to...
Read More
1 Minute
Medicine

Mestag Therapeutics awarded £1.5m Innovate UK grant to accelerate the Path to Clinic for MST-0300

Mestag Therapeutics, a biotech company harnessing new insights into fibroblast-immune interactions, has announced that it has been awarded a “Transforming Cancer Therapeutics” grant from Innovate UK’s Cancer Therapeutics program of 1.5 million GBP (1.9...
Read More
2 Minutes
Medicine

Adcendo ApS and Multitude Therapeutics Inc Sign Licensing Agreement for an ADC Drug Candidate Targeting Tissue Factor

Adcendo ApS (Adcendo) and Multitude Therapeutics Inc (Multitude) have signed a licensing agreement regarding the development of a highly differentiated antibody-drug conjugate (ADC) targeting Tissue Factor (TF), known as ADCE-T02. As part of the...
Read More
2 Minutes
Medicine

Everest Medicines announces Investigator-Initiated Clinical Trial for cancer vaccine programme

Everest Medicines has announced the launch of an Investigator-Initiated Clinical Trial (IIT) for a personalised mRNA cancer vaccine, EVM16, under the study EVM16CX01, at the Peking University Cancer Hospital and Fudan University’s Cancer Hospital....
Read More
1 Minute
Medicine

QuantaMatrix Develops “the World’s Fastest” All-in-One Antimicrobial Testing Technology

QuantaMatrix has unveiled what it’s calling “the world’s fastest” all-in-one antimicrobial testing technology. The uRAST (ultra-rapid antimicrobial susceptibility testing) solution has recently been published in the scientific journal, Nature. Traditionally, antimicrobial testing methods can...
Read More
1 Minute
Medicine

AstraZeneca and Daiichi Sankyo Receives Chinese Approval for Gastric Cancer Therapy

AstraZeneca and Daiichi Sankyo have announced that the duo’s antibody-drug conjugate (ADC), Enhertu (trastuzumab deruxtecan), has received conditional approval from the China National Medical Products Administration (NMPA) for gastric cancer. Now, Enhertu can be used as...
Read More
1 Minute
Medicine

NorthStar and Convergent Expands Collaboration with its Prostate Cancer Treatment

NorthStar Medical Radioisotopes (NorthStar) and Convergent Therapeutics (Convergent) are set to expand its collaboration relating to the CONV01-a treatment for prostate cancer. The duo explains its new drug by detailing that “CONV01-a is a prostate-specific membrane antigen-targeted...
Read More
3 Minutes
Medicine

NHS requires compliance with BSI Kitemark to promote responsible antibiotic manufacturing

Pharmaceutical companies bidding for the newly launched NHS Antimicrobial Product subscription model will be required to demonstrate the steps they are taking to promote responsible antibiotic manufacturing and minimise the risk of antimicrobial resistance...
Read More
1 Minute
Medicine

Vertex announces CASGEVY reimbursment agreement for treatment of transfusion-dependent beta thalassaemia in England

Vertex Pharmaceuticals has announced a reimbursement agreement with NHS England for eligible transfusion-dependent beta thalassaemia (TDT) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY (exagamglogene autotemcel), from August 8, 2024. The reimbursement agreement comes as the...
Read More
1 Minute
Medicine

Calibre Scientific Acquires Spanish Biotechnology Laboratory Consumables and Equipment Supplier

Calibre Scientific has announced its acquisition of the Spanish distributor of biotechnology laboratory consumables and equipment, ACEFE, S.A.U (ACEFESA). ACEFESA, which is Calibre Scientific’s fifth acquisition in Spain, has an established position in the...
Read More
2 Minutes
Medicine

Beckman Coulter Life Sciences and Illumina launch TruSight Oncology 500 DNA/RNA application

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, in partnership with Illumina, a leader in DNA sequencing and array-based technologies, has launched the a ‘promising new approach’ to oncology research delivering...
Read More
2 Minutes
Medicine

Eisai selects Medidata’s Clinical Data Studio to enhance clinical trial efficiency and patient experience

Medidata, a Dassault Systèmes brand and provider of clinical trial solutions to the life sciences industry, has announced Eisai Inc, the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., as one of the first customers...
Read More
1 Minute
Medicine

CSafe launches reusable Silverpod pallet shipper to help pharma companies reach sustainability targets

CSafe, a provider of active and passive temperature-controlled shipping solutions for the pharmaceutical industry, has announced the launch of a new reusable pallet shipper, the Silverpod MAX RE, with multiple updated features. The new and improved product...
Read More
1 Minute
Medicine

Calliditas Therapeutics secures full marketing authorisation from the European Commission

Calliditas Therapeutics has announced that it has received full marketing authorisation from the European Commission regarding the biopharma company’s Kinpeygo treatment for adults with primary immunoglobulin A nephropathy (IgAN). This allows for a broader label...
Read More
3 Minutes
Medicine

Otsuka and Oxford HIN collaborate to gather insights into digital therapeutics for mental health

Otsuka Pharmaceutical Europe Ltd. and Otsuka Pharmaceuticals (U.K.) Ltd. (Otsuka) are collaborating with Health Innovation Oxford & Thames Valley (Oxford HIN) to evaluate the implementation and integration of a new digital therapeutic (DTx), CARE for MDD, intended to support...
Read More